Caturkarda Depo Bangunan Annual cash flow by MarketWatch. View DEPO net cash flow, operating cash flow, operating expenses and cash dividends.

Depomed's full-year guidancce has been slightly altered, moving from in the range of $485 million to $525 million, to the range of $490 million to $520 million. DEPO stock is up 14.7% Monday.

DEPO-PROVERA may cause dizziness, sleepiness or affect vision in some people. Make sure you know how you react to DEPO-PROVERA before driving a car or operating machinery.

The net income for the quarter ended September 30, 2017 was $189.1 million or $5.25 per share compared to a net loss of $60.9 million or $1.71 per share for the same period in 2016. Collaboration ...